cytopathology-2017-keynote

3 / 5

Volume 8, Issue 2 (Suppl) J Cytol Histol, an open access journal
ISSN: 2157-7099 Cytopathology 2017
June 21-22, 2017
Page 25
Notes:
conferenceseries.com
June 21-22, 2017 Philadelphia, USA
3rd International Conference on
Cytopathology & Histopathology
Yun Gong, J Cytol Histol 2017, 8:2 (Suppl)
DOI: 10.4172/2157-7099-C1-010
The role of cytology in the era of molecular medicine
Genomic alterations are known to play an important role in cancer initiation and progression. Molecular tests have been
increasingly incorporated into pathology practice. Common applications include assisting pathology diagnosis, predicting
prognosis and therapeutic response and identifying patient’s eligibility for targeted therapy. The lecture will outline the role
of molecular tests in the diagnosis of HPV-related cancer, thyroid cancer, hematopoietic malignancies, detection of tumor of
unknown origin and management of lung cancer, breast cancer and other solid tumors. To successfully conduct molecular
tests, a high quality tumor sample is imperative. The lecture covers practical experience of MD Anderson and covers the
strategies regarding how to use small and limited FNA samples for making the most informative diagnosis and yet preserve
tumor tissues for cytogenetic and genomic tests that, in turn, facilitate diagnosis and targeted therapies.
Biography
Yun Gong has received MD degree in 1984 and then completed her Post-graduate Pathology training in 1989 at Zhejiang Medical University in China. She has
then worked as a Post-Doctor and Research Associate in the Shanghai Institute of Cell Biology, Chinese Academy of Sciences; Catholic University of Nijmegen,
Netherlands and The Scripps Research Institute, California. She has received her Residency training in Anatomic and Clinical Pathology at Northwestern University
Medical School in Chicago followed by one-year Cytopathology Fellowship training at MD Anderson Cancer Center. She became a Faculty Member at the
Department of Pathology, MD Anderson Cancer Center in 2003 and currently is a Full Professor. She has numerous publications in the fields of cytopathology and
breast cancer biomarker research (120 peer-review articles, 18 invited articles, 6 book chapters, 1 book and 118 abstracts). She is a Member of 9 Editorial Boards
of professional journals and is a Member of the Scientific Program Committee, American Society of Cytopathology (ASC).
Yun Gong
MD Anderson Cancer Center, USA